The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
STOPP/START criteria for potentially inappropriate prescribing in older people: version 2
Open accessAbstract
Purpose: screening tool of older people's prescriptions (STOPP) and screening tool to alert to right treatment (START) criteria were first published in 2008. Due to an expanding therapeutics evidence base, updating of the criteria was required. Methods: we reviewed the 2008 STOPP/START criteria to add new evidence-based criteria and remove any obsolete criteria. A thorough literature review was performed to reassess the evidence base of the 2008 criteria and the proposed new criteria. Nineteen experts from 13 European countries reviewed a new draft of STOPP & START criteria including proposed new criteria. These experts were also asked to propose additional criteria they considered important to include in the revised STOPP & START criteria and to highlight any criteria from the 2008 list they considered less important or lacking an evidence base. The revised list of criteria was then validated using the Delphi consensus methodology. Results: the expert panel agreed a final list of 114 criteria after two Delphi validation rounds, i.e. 80 STOPP criteria and 34 START criteria. This represents an overall 31% increase in STOPP/START criteria compared with version 1. Several new STOPP categories were created in version 2, namely antiplatelet/anticoagulant drugs, drugs affecting, or affected by, renal function and drugs that increase anticholinergic burden; new START categories include urogenital system drugs, analgesics and vaccines. Conclusion: STOPP/START version 2 criteria have been expanded and updated for the purpose of minimizing inappropriate prescribing in older people. These criteria are based on an up-to-date literature review and consensus validation among a European panel of experts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evidence-Based Medicine: How to Practice and Teach EBM
Sackett, D. L. (2000) · Cited by 5,950
The American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03923.x · Cited by 2,578
Evidence-Based Medicine: How to Practice and Teach EBM
Satya-Murti, S. (2000) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.284.18.2382 · Cited by 1,643
Gallagher, P., Ryan, C., Byrne, S., Kennedy, J., & OMahony, D. (2008) · Int. Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp46072 · Cited by 1,506
Self-citationHamilton, H., Gallagher, P., Ryan, C., Byrne, S., & O’Mahony, D. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.215 · Cited by 566
Self-citationGallagher, P. F., O'Connor, M. N., & O'Mahony, D. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.44 · Cited by 505
Self-citationInappropriate Prescribing: Criteria, Detection and Prevention
OʼConnor, M. N., Gallagher, P., & OʼMahony, D. (2012) · Drugs & Aging · doi:10.2165/11632610-000000000-00000 · Cited by 351
Self-citationThe Epidemiology of Serious Adverse Drug Reactions Among the Elderly
Atkin, P. A., Veitch, P. C., Veitch, E. M., & Ogle, S. J. (1999) · Drugs & Aging · doi:10.2165/00002512-199914020-00005 · Cited by 203
Strategies to reduce the risk of iatrogenic illness in complex older adults
Onder, G., van der Cammen, T. J. M., Petrović, M., Somers, A., & Rajkumar, C. (2013) · Age and Ageing · doi:10.1093/ageing/aft038 · Cited by 138
Quality of drug prescribing in older patients: is there a problem and can we improve it?
Scott, I. A., & Jayathissa, S. (2009) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2009.02040.x · Cited by 82
Cited by
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15767 · Cited by 3,163
By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13702 · Cited by 2,609
World guidelines for falls prevention and management for older adults: a global initiative
Montero-Odasso, M., van der Velde, N., Martin, F. C., Petrovic, M., Tan, M. P., Ryg, J., Aguilar-Navarro, S., Alexander, N. B., Becker, C., Blain, H., et al. (2022) · Age and Ageing · doi:10.1093/ageing/afac205 · Cited by 1,756
Management of frailty: opportunities, challenges, and future directions
Dent, E., Martin, F. C., Bergman, H., Woo, J., Romero-Ortuno, R., & Walston, J. D. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31785-4 · Cited by 1,678
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446
Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management
Dent, E., Morley, J. E., Cruz-Jentoft, A. J., Woodhouse, L., Rodríguez-Mañas, L., Fried, L. P., Woo, J., Aprahamian, I., Sanford, A., Lundy, J., et al. (2019) · The Journal of nutrition, health and aging · doi:10.1007/s12603-019-1273-z · Cited by 1,049
Management of Depression in Older Adults: A Review
Kok, R. M., & Reynolds, C. F. (2017) · JAMA · doi:10.1001/jama.2017.5706 · Cited by 890
Kim, D. H., & Rockwood, K. (2024) · New England Journal of Medicine · doi:10.1056/nejmra2301292 · Cited by 824
STOPP/START criteria for potentially inappropriate prescribing in older people: version 3
O’Mahony, D., Cherubini, A., Guiteras, A. R., Denkinger, M., Beuscart, J.-B., Onder, G., Gudmundsson, A., Cruz-Jentoft, A. J., Knol, W., Bahat, G., et al. (2023) · European Geriatric Medicine · doi:10.1007/s41999-023-00777-y · Cited by 703
An update on the clinical consequences of polypharmacy in older adults: a narrative review
Wastesson, J. W., Morin, L., Tan, E. C. K., & Johnell, K. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1546841 · Cited by 617
The Asia-Pacific Clinical Practice Guidelines for the Management of Frailty
Dent, E., Lien, C., Lim, W. S., Wong, W. C., Wong, C. H., Ng, T. P., Woo, J., Dong, B., de la Vega, S., Hua Poi, P. J., et al. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.04.018 · Cited by 631
Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences
Pazan, F., & Wehling, M. (2021) · European Geriatric Medicine · doi:10.1007/s41999-021-00479-3 · Cited by 542
Renom-Guiteras, A., Meyer, G., & Thürmann, P. A. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1860-9 · Cited by 483
Predicting risk of adverse drug reactions in older adults
Lavan, A. H., & Gallagher, P. (2016) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098615615472 · Cited by 455
Self-citationMuth, C., Blom, J. W., Smith, S. M., Johnell, K., Gonzalez‐Gonzalez, A. I., Nguyen, T. S., Brueckle, M. ‐., Cesari, M., Tinetti, M. E., & Valderas, J. M. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12842 · Cited by 339
Boyd, C., Smith, C. D., Masoudi, F. A., Blaum, C. S., Dodson, J. A., Green, A. R., Kelley, A., Matlock, D., Ouellet, J., Rich, M. W., et al. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15809 · Cited by 313
Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes
Lipska, K. J., Krumholz, H., Soones, T., & Lee, S. J. (2016) · JAMA · doi:10.1001/jama.2016.0299 · Cited by 309
Medication review in hospitalised patients to reduce morbidity and mortality
Christensen, M., & Lundh, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008986.pub3 · Cited by 298
Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many
Cadogan, C. A., Ryan, C., & Hughes, C. M. (2016) · Drug Safety · doi:10.1007/s40264-015-0378-5 · Cited by 298
Self-citationTommelein, E., Mehuys, E., Petrovic, M., Somers, A., Colin, P., & Boussery, K. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1954-4 · Cited by 292
Lavan, A. H., Gallagher, P., Parsons, C., & O'Mahony, D. (2017) · Age and Ageing · doi:10.1093/ageing/afx005 · Cited by 290
Self-citationAdverse drug reactions in older adults: a narrative review of the literature
Zazzara, M. B., Palmer, K., Vetrano, D. L., Carfì, A., & Onder, G. (2021) · European Geriatric Medicine · doi:10.1007/s41999-021-00481-9 · Cited by 283
Morin, L., Laroche, M.-L., Texier, G., & Johnell, K. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.06.011 · Cited by 280
Motter, F. R., Fritzen, J. S., Hilmer, S. N., Paniz, É. V., & Paniz, V. M. V. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2446-0 · Cited by 276
Polypharmacy, hospitalization, and mortality risk: a nationwide cohort study
Chang, T. I., Park, H., Kim, D. W., Jeon, E. K., Rhee, C. M., Kalantar-Zadeh, K., Kang, E. W., Kang, S.-W., & Han, S. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-75888-8 · Cited by 263
Polypharmacy and Medication Management in Older Adults
Kim, J., & Parish, A. L. (2017) · Nursing Clinics of North America · doi:10.1016/j.cnur.2017.04.007 · Cited by 245
Domain Management Approach to Heart Failure in the Geriatric Patient
Gorodeski, E. Z., Goyal, P., Hummel, S. L., Krishnaswami, A., Goodlin, S. J., Hart, L. L., Forman, D. E., Wenger, N. K., Kirkpatrick, J. N., & Alexander, K. P. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.059 · Cited by 259
Seppala, L. J., Petrovic, M., Ryg, J., Bahat, G., Topinkova, E., Szczerbińska, K., van der Cammen, T. J. M., Hartikainen, S., Ilhan, B., Landi, F., et al. (2021) · Age and Ageing · doi:10.1093/ageing/afaa249 · Cited by 255
Self-citationNg, B. J., Le Couteur, D. G., & Hilmer, S. N. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0544-4 · Cited by 118
Polypharmacy and inappropriate medication use in patients with dementia: an underresearched problem
Parsons, C. (2017) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098616670798 · Cited by 113
Bénard-Laribière, A., Pariente, A., Pambrun, E., Bégaud, B., Fardet, L., & Noize, P. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-015905 · Cited by 111
Identifying potentially inappropriate prescribing in older people with dementia: a systematic review
Hukins, D., Macleod, U., & Boland, J. W. (2019) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-02612-x · Cited by 84
Evrard, P., Pétein, C., Beuscart, J.-B., & Spinewine, A. (2022) · Implementation Science · doi:10.1186/s13012-022-01206-7 · Cited by 62
Wiels, W. A., Wittens, M. M. J., Zeeuws, D., Baeken, C., & Engelborghs, S. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.707580 · Cited by 52
Houlind, M. B., Andersen, A. L., Treldal, C., Jørgensen, L. M., Kannegaard, P. N., Castillo, L. S., Christensen, L. D., Tavenier, J., Rasmussen, L. J. H., Ankarfeldt, M. Z., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020348 · Cited by 48
Izza, M. A. D., Lunt, E., Gordon, A. L., Gladman, J. R. F., Armstrong, S., & Logan, P. (2020) · European Geriatric Medicine · doi:10.1007/s41999-020-00376-1 · Cited by 48
Cossette, B., Bruneau, M.-A., Couturier, Y., Gilbert, S., Boyer, D., Ricard, J., McDonald, T., Labarre, K., Déry, V., Arcand, M., et al. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.08.027 · Cited by 47
STOPP/START version 2—development of software applications: easier said than done?
Anrys, P., Boland, B., Degryse, J.-M., De Lepeleire, J., Petrovic, M., Marien, S., Dalleur, O., Strauven, G., Foulon, V., & Spinewine, A. (2016) · Age and Ageing · doi:10.1093/ageing/afw114 · Cited by 37
Stakeholders' views on the use of psychotropic medication in older people: a systematic review
Bednarczyk, E., Cook, S., Brauer, R., & Garfield, S. (2022) · Age and Ageing · doi:10.1093/ageing/afac060 · Cited by 22
Polypharmacy and precision medicine
Fujita, K., Masnoon, N., Mach, J., O’Donnell, L. K., & Hilmer, S. N. (2023) · Cambridge Prisms: Precision Medicine · doi:10.1017/pcm.2023.10 · Cited by 27
Gardner, D. M., Turner, J. P., Magalhaes, S., Rajda, M., & Murphy, A. L. (2024) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2024.2731 · Cited by 19
Inskip, M., Almendrales Rangel, C., Njoku, C. M., Barnett, F., Shih, I., O’Neill, L., Fiatarone Singh, M. A., & Valenzuela, T. (2024) · Methods and Protocols · doi:10.3390/mps7020026 · Cited by 3
Metadata
- Authors
- O'Mahony, D., O'Sullivan, D., Byrne, S., O'Connor, M. N., Ryan, C., & Gallagher, P.
- Venue
- Age and Ageing
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-10-16
- Volume
- 44
- Issue
- 2
- Pages
- 213-218
- ISSN
- 0002-0729 (ISSN-L)
- 1468-2834
- OpenAlex
- W2130510785
- Cited by
- 2,397
- References
- 13
- FWCI
- 60.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.